{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:23Z","timestamp":1740107603235,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T00:00:00Z","timestamp":1440806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00428-015-1823-7","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T08:05:03Z","timestamp":1440749103000},"page":"383-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity"],"prefix":"10.1007","volume":"467","author":[{"given":"Pedro","family":"Queir\u00f3s","sequence":"first","affiliation":[]},{"given":"Hugo","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Irene","family":"Gullo","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"Gabriela M","family":"Almeida","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8340-2264","authenticated-orcid":false,"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,8,29]]},"reference":[{"key":"1823_CR1","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin. doi: 10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1823_CR2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ctrv.2014.03.002","volume":"40","author":"F Lordick","year":"2014","unstructured":"Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P, Van Cutsem E, van de Velde C, Cervantes A (2014) Unmet needs and challenges in gastric cancer: the way forward. Cancer Treat Rev 40(6):692\u2013700. doi: 10.1016\/j.ctrv.2014.03.002","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"1823_CR3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12094-012-0836-9","volume":"14","author":"F Rivera","year":"2012","unstructured":"Rivera F, Gravalos C, Garcia-Carbonero R, SEOM (2012) SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma. Clinical & Translational oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 14(7):528\u2013535. doi: 10.1007\/s12094-012-0836-9","journal-title":"Clinical & Translational oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"issue":"7","key":"1823_CR4","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.ejca.2014.01.029","volume":"50","author":"A Ferro","year":"2014","unstructured":"Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Worldwide trends in gastric cancer mortality (1980\u20132011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50(7):1330\u20131344. doi: 10.1016\/j.ejca.2014.01.029","journal-title":"Eur J Cancer"},{"issue":"6","key":"1823_CR5","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/gast.2002.37070","volume":"123","author":"N Suraweera","year":"2002","unstructured":"Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy K, Seruca R, Iacopetta B, Hamelin R (2002) Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123(6):1804\u20131811. doi: 10.1053\/gast.2002.37070","journal-title":"Gastroenterology"},{"issue":"22","key":"1823_CR6","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58(22):5248\u20135257","journal-title":"Cancer Res"},{"issue":"4","key":"1823_CR7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)65665-9","volume":"153","author":"C Oliveira","year":"1998","unstructured":"Oliveira C, Seruca R, Seixas M, Sobrinho-Simoes M (1998) The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different \u201ctarget genes\u201d: a study of the TGFbeta RII, IGFII R, and BAX genes. The American Journal of Pathology 153(4):1211\u20131219","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"1823_CR8","first-page":"1609","volume":"62","author":"A Duval","year":"2002","unstructured":"Duval A, Reperant M, Compoint A, Seruca R, Ranzani GN, Iacopetta B, Hamelin R (2002) Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency. Cancer Res 62(6):1609\u20131612","journal-title":"Cancer Res"},{"key":"1823_CR9","doi-asserted-by":"crossref","unstructured":"Oliveira C, Pinto M, Duval A, Brennetot C, Domingo E, Espin E, Armengol M, Yamamoto H, Hamelin R, Seruca R, Schwartz Jr S (2003) BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene 22(57):9192\u20139196. doi: 10.1038\/sj.onc.1207061","DOI":"10.1038\/sj.onc.1207061"},{"issue":"22","key":"1823_CR10","doi-asserted-by":"crossref","first-page":"12122","DOI":"10.1073\/pnas.94.22.12122","volume":"94","author":"S Olschwang","year":"1997","unstructured":"Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, Muzeau F, Girodet J, Salmon RJ, Thomas G (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A 94(22):12122\u201312127","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1823_CR11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0002-9440(10)64102-8","volume":"158","author":"WS Samowitz","year":"2001","unstructured":"Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, Leppert MF, Slattery ML (2001) Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. The American Journal of Pathology 158(4):1517\u20131524. doi: 10.1016\/S0002-9440(10)64102-8","journal-title":"The American Journal of Pathology"},{"key":"1823_CR12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2407-8-255","volume":"8","author":"S Velho","year":"2008","unstructured":"Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R (2008) BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 8:255. doi: 10.1186\/1471-2407-8-255","journal-title":"BMC Cancer"},{"key":"1823_CR13","doi-asserted-by":"crossref","unstructured":"Brennetot C, Duval A, Hamelin R, Pinto M, Oliveira C, Seruca R, Schwartz Jr S (2003) Frequent Ki-ras mutations in gastric tumors of the MSI phenotype. Gastroenterology 125(4):1282","DOI":"10.1016\/j.gastro.2003.02.002"},{"issue":"7407","key":"1823_CR14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330\u2013337. doi: 10.1038\/nature11252","journal-title":"Nature"},{"key":"1823_CR15","doi-asserted-by":"crossref","unstructured":"Nicholson RI, Gee JM, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37 Suppl4:S9-15","DOI":"10.1016\/S0959-8049(01)00231-3"},{"issue":"15","key":"1823_CR16","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","volume":"29","author":"E Cutsem Van","year":"2011","unstructured":"Van Cutsem E, Kohne CH, Lang I, Folprecht G, Nowacki MP, Cascinu S, Shchepotin I, Maurel J, Cunningham D, Tejpar S, Schlichting M, Zubel A, Celik I, Rougier P, Ciardiello F (2011) Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29(15):2011\u20132019. doi: 10.1200\/JCO.2010.33.5091","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"issue":"6","key":"1823_CR17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","volume":"14","author":"F Lordick","year":"2013","unstructured":"Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, Kurteva G, Volovat C, Moiseyenko VM, Gorbunova V, Park JO, Sawaki A, Celik I, Gotte H, Melezinkova H, Moehler M, Arbeitsgemeinschaft Internistische O, Investigators E (2013) Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. The Lancet Oncology 14(6):490\u2013499. doi: 10.1016\/S1470-2045(13)70102-5","journal-title":"The Lancet Oncology"},{"issue":"7517","key":"1823_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202\u2013209. doi: 10.1038\/nature13480","journal-title":"Nature"},{"issue":"12","key":"1823_CR19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","volume":"6","author":"LM Merlo","year":"2006","unstructured":"Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6(12):924\u2013935. doi: 10.1038\/nrc2013","journal-title":"Nat Rev Cancer"},{"key":"1823_CR20","first-page":"40","volume":"6","author":"M Anaka","year":"2013","unstructured":"Anaka M, Hudson C, Lo PH, Do H, Caballero OL, Davis ID, Dobrovic A, Cebon J, Behren A (2013) Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors. BMC Med Genet 6:40. doi: 10.1186\/1755-8794-6-40","journal-title":"BMC Med Genet"},{"issue":"4","key":"1823_CR21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ng1768","volume":"38","author":"CC Maley","year":"2006","unstructured":"Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38(4):468\u2013473. doi: 10.1038\/ng1768","journal-title":"Nat Genet"},{"key":"1823_CR22","author":"P Laurent-Puig","year":"2014","unstructured":"Laurent-Puig P, Pekin D, Normand C, Kotsopoulos SK, Nizard P, Perez-Toralla K, Rowell R, Olson J, Srinivasan P, Le Corre D, Hor T, El Harrak Z, Li X, Link DR, Bouche O, Emile JF, Landi B, Boige V, Hutchison JB, Taly V (2014) Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. doi: 10.1158\/1078-0432.CCR-14-0983","journal-title":"Clinical Cancer Research : an Official Journal of the American Association for Cancer Research"},{"issue":"2","key":"1823_CR23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/labinvest.2009.132","volume":"90","author":"M Jiang","year":"2010","unstructured":"Jiang M, Zhang Y, Fei J, Chang X, Fan W, Qian X, Zhang T, Lu D (2010) Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces. Laboratory Investigation; a Journal of Technical Methods and Pathology 90(2):282\u2013290. doi: 10.1038\/labinvest.2009.132","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"key":"1823_CR24","doi-asserted-by":"crossref","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science signaling 6(269):pl1. doi:10.1126\/scisignal.2004088","DOI":"10.1126\/scisignal.2004088"},{"issue":"5","key":"1823_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery 2(5):401\u2013404. doi: 10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discovery"},{"issue":"24","key":"1823_CR26","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1093\/bioinformatics\/btp583","volume":"25","author":"IM Carr","year":"2009","unstructured":"Carr IM, Robinson JI, Dimitriou R, Markham AF, Morgan AW, Bonthron DT (2009) Inferring relative proportions of DNA variants from sequencing electropherograms. Bioinformatics 25(24):3244\u20133250. doi: 10.1093\/bioinformatics\/btp583","journal-title":"Bioinformatics"},{"issue":"1","key":"1823_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12876-015-0231-4","volume":"15","author":"P Stahl","year":"2015","unstructured":"Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki JR, Bokemeyer C, Simon R, Sauter G, Marx AH (2015) Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. BMC Gastroenterol 15(1):7. doi: 10.1186\/s12876-015-0231-4","journal-title":"BMC Gastroenterol"},{"key":"1823_CR28","doi-asserted-by":"crossref","unstructured":"Normanno N, Rachiglio AM, Lambiase M, Martinelli E, Fenizia F, Esposito C, Roma C, Troiani T, Rizzi D, Tatangelo F, Botti G, Maiello E, Colucci G, Ciardiello F, on the behalf of the C-Gi (2015) Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial. Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO. doi: 10.1093\/annonc\/mdv176","DOI":"10.1093\/annonc\/mdv176"},{"key":"1823_CR29","doi-asserted-by":"crossref","unstructured":"Velho S, Oliveira C, Ferreira A, Ferreira AC, Suriano G, Schwartz Jr S, Duval A, Carneiro F, Machado JC, Hamelin R, Seruca R (2005) The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 41(11):1649\u20131654. doi: 10.1016\/j.ejca.2005.04.022","DOI":"10.1016\/j.ejca.2005.04.022"},{"key":"1823_CR30","doi-asserted-by":"crossref","unstructured":"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, Group EGW (2014) Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology\/ESMO 25 Suppl 3:iii1-9. doi:10.1093\/annonc\/mdu260","DOI":"10.1093\/annonc\/mdu260"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-015-1823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-015-1823-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-015-1823-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:22:29Z","timestamp":1559064149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-015-1823-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,29]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s00428-015-1823-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"type":"print","value":"0945-6317"},{"type":"electronic","value":"1432-2307"}],"subject":[],"published":{"date-parts":[[2015,8,29]]}}}